Three new trials of HIV prevention drugs seek to answer directly a question that researchers inside and outside the field of HIV have explicitly avoided for years: How do drugs work -- and are they safe -- in pregnant and breastfeeding women?
At USCA 2018, Black Lives Matter Cofounder Alicia Garza Discusses HIV and Building Black Social Justice Power
Alicia Garza talks with TheBodyPRO's Kenyon Farrow about HIV's relative invisibility in black social justice spaces, despite its disproportionate impact on black communities.
To Understand Challenges Black Men With HIV Face on Re-Entry From Prisons, an Intersectional Approach Is Needed, Study Shows
There are multiple reasons why re-entry into communities from prison for black men with HIV is a difficult proposition, according to a recent study.
People living with HIV whose virus is completely, durably suppressed by treatment will not sexually transmit the virus to an HIV-negative partner, according to NIAID Director Anthony S. Fauci, M.D.
The risk of transmitting HIV through the breastmilk of virally suppressed women in high-income countries is not known.
Reported 'PrEP Failure' in Thailand May Be a Result of Missing Acute HIV Infection: Here's What You Need to Know
The Infectious Diseases Society of America reported on June 29, 2018, that a new HIV acquisition had been found in a person using pre-exposure prophylaxis (PrEP).
"It is hard to imagine how in 2018 we could be in this situation where women with HIV are being so woefully underserved," Polly Clayden writes.
Leading researchers and clinicians who influence best practices for conversations about the direct and indirect impact of HIV infection and treatment agree that communications regarding transmission must shift.
"The LGBTQ community needs health care providers to open their eyes and commit to our health, well-being, and healing," Jessica Halem writes. "We need them to be aware of our history and the reasons why so many of us don't trust that doctors and nurs...
Three researchers talk about ongoing HIV cure research within the AIDS Clinical Trials Group, treatment interruptions, and when we might see a cure.